🤝 CRWV $8.5M Hedged Volatility Package — Delta-Neutral Put Cross and a Bullish Lit Call Buy (Not Bearish)

📅 June 29, 2026 | 🔥 Unusual Activity Detected

✅ Update (2026-06-30): Next-day OPRA OI confirms both legs OPENED — the $75 put 1,808 → 5,751 (Δ +3,943, ≈99% of the 4,000 print) and the $97 call 78 → 1,580 (Δ +1,502, full size). The interpretation holds; see the resolved box below.

---

🎯 The Quick Take

Two separate tape events on CoreWeave (CRWV) today tell a nuanced story: a ≈$7.4M put crossed in a negotiated QCC block — but it was paired with a 96,000-share stock hedge, making it a delta-neutral long-volatility package, not a bearish directional bet. A separate ≈$1.1M near-term call printed on the lit tape at 90% NBBO aggressor (= a genuine buy, despite the screenshot mislabeling it a "SELL"). Net read: neutral-to-mildly-bullish on CRWV — one desk is buying volatility insurance, another is taking near-term upside, and neither print is the headline "$7.4M bearish put" a screenshot-only read would suggest.

---

📊 Company Overview

CoreWeave, Inc. (CRWV) is an AI hyperscaler and specialized GPU-cloud provider — one of the purest public plays on the AI-infrastructure build-out:

• 💰 Market Cap: ≈$52–53B (late June 2026), per Capital.com and stockanalysis.com
• 🏭 Industry: Information Technology — AI/Cloud Infrastructure ("neo-cloud" / GPU-as-a-service)
• 📈 Current Price: ≈$95.27 (June 29, 2026), per Investing.com
• 🤖 Business: CoreWeave rents large fleets of NVIDIA GPUs for AI training and inference to Meta, OpenAI, Anthropic, Google, and Microsoft. Revenue was $2.08B in Q1 2026, up 112% YoY, per CoreWeave IR
• 🚀 IPO: Priced March 27, 2025 at $40/share, per CNBC — barely 15 months old as a public company

⚠️ Critical context before reading the flow: CRWV is a young, highly volatile post-IPO name with ≈$21–25B of debt (debt/equity ≈641%), deeply negative free cash flow (−$4.7B in Q1 2026), customer concentration, and recurring dilution risk, per The Motley Fool and financecharts. The options market prices this correctly: implied volatility runs ≈85–90%, meaning options are expensive because CRWV can genuinely move ±20–40% on single catalysts. That high-IV environment is itself the story behind the put cross.

---

💰 The Option Flow Breakdown

📊 Full Trade Table — Two Separate Tape Events

Two distinct prints on CRWV today (spot ≈$94.2–$95.2):

Paired equity block (contingent on Trade 1 — printed 252ms later):

⚠️ Tape correction — $97 call was BOUGHT, not sold: The screenshot labels this trade as a "SELL." The OPRA tape tells a different story: the print filled at 90% across the NBBO (near the ask), which is unambiguously a buy-side aggressor fill. A fill near the ask means the buyer was taking the offer, not a seller collecting premium. The tape is ground truth; the screenshot is wrong. All analysis below reflects the tape.

---

✅ OI RESOLVED (2026-06-30) — BOTH LEGS OPEN CONFIRMED

The next-day OPRA OI snapshot (EOD 2026-06-29, posted 2026-06-30 ≈06:30 ET) is in: both legs opened as predicted, with no inversion. The $75 put added +3,943 of OI against a 4,000-contract print (≈99% net-new — very little transfer), and the $97 call added +1,502 against a 1,500-contract print (full size). The article's interpretation holds.

---

🤓 What This Actually Means — Plain English

Let me walk through each trade carefully, because misreading either one would give you the wrong thesis entirely.

---

Trade 1: The $7.4M $75 Put — A Hedged Long-Vol Package, NOT a Bearish Bet (12:43:58)

A block cross means a broker matched a known buyer and a known seller off the public book at a pre-arranged price. This is not someone urgently hitting the ask to express a bearish view. It is a negotiated, facilitated block — and the full picture only becomes clear when you add the equity tape.

Here is the critical detail: 96,000 shares of CRWV crossed at $93.15 — a Qualified Contingent Trade (QCT) — just 252ms after the put cross. A QCT is explicitly a stock block that is contingent on an option transaction. In plain English: the put and the stock block were pre-arranged as a single package.

The delta math confirms it:

• Strike $75, spot ≈$94.2, ≈354 days to expiration, implied volatility ≈90%
• Independent put delta at these parameters: ≈ −0.22 to −0.24
• Implied delta from the stock block: 96,000 shares ÷ (4,000 contracts × 100 shares/contract) = 0.24
• ✅ Match. The stock block is sized to delta-offset the put position.

What this means: A desk bought 4,000 puts and simultaneously offset the negative delta with ≈96,000 shares of stock (or the equivalent in a cross). The combined package — long put plus long stock — is roughly delta-neutral at inception. It is not a clean bearish bet; it is a long-volatility / long-gamma position.

This structure profits from:

• ✅ A very large move in CRWV in either direction (positive gamma)
• ✅ An expansion in implied volatility (positive vega) — relevant in a name where IV can swing from 70% to 110%
• ❌ It loses from time decay (negative theta) if the stock stays flat and IV stays stable

The most plausible frames for this package:

1. Protective put + long stock: A desk that owns (or is buying) CRWV shares and wants tail protection at $75 (≈21% below the trade-time spot of $94.22). This is the "institutional insurance" read.
2. Long gamma / vol trade into upcoming binary catalysts: CRWV has Q2 earnings on ≈August 18, 2026 — well inside this put's June 2027 expiry. A vol trader might be positioning for volatility expansion into the earnings binary at a name where IV is already structurally elevated.

What this is NOT:

• ❌ Not a straightforward bearish bet that CRWV goes to $75
• ❌ Not an urgent sweep by someone in a hurry to get short
• ❌ Not comparable to buying a standalone put as a directional trade

The $75 put's breakeven at expiry (June 17, 2027) is $75 − $18.45 = $56.55 — the stock would need to fall ≈40% below current levels for the pure long-put leg to be in profit at expiration. But again, this is a delta-hedged position, so the desk is not simply waiting for a 40% drop.

---

Trade 2: The $1.1M $97 Call — A Clean Bullish BUY (12:47:51, Tape Corrects the Screenshot)

Four minutes after the put cross, 1,500 contracts of the July 24, 2026 $97 calls printed on the lit tape (regular displayed-book execution — no negotiation, no crossing). This is the simpler trade:

• 📈 90% NBBO aggressor = the buyer was paying near the ask, a clear buy-side fill
• 📊 Size 1,500 vs. prior OI 78 = ≈19× prior OI, a fresh opening position with HIGH confidence
• ⚡ Lit tape = this is real aggression, someone willing to pay up to get the position
• 🎯 Strike $97, spot ≈$94.4 = ≈2.7% out-of-the-money, expiring July 24, 2026 (≈25 days)

This is a bullish BTO (Buy to Open) of 1,500 near-term calls. The buyer paid $7.40 per contract (total ≈$1.1M debit) and profits if CRWV trades above $104.40 (= $97 + $7.40) at expiration.

Note: the July 24 expiry is before Q2 2026 earnings (≈August 18, 2026). This is a near-term call buy — the buyer is betting on a move within the next 25 days, not into earnings. That could reflect a technical setup, an expected near-term catalyst announcement (new customer contract, NVIDIA news), or simply positioning around the current ≈$95 level.

The screenshot labeled this "SELL" — that would have been a put seller collecting premium, a completely different trade. The OPRA tape's 90% NBBO aggressor reading is unambiguous: this was bought.

---

Are these the same desk?

The two trades printed 4 minutes apart on the same stock. Whether they are the same desk or two separate desks is unknowable from the tape. Two readings:

• Same desk: One sophisticated player bought a delta-hedged long-vol put package AND a near-term directional call. Net: slightly long-vol with a near-term upside lean. This would be a desk that wants gamma/vega exposure while also owning some clean near-term upside optionality.
• Two different desks: One desk is buying long-vol insurance (hedged put), and a separate desk is taking near-term bullish exposure (lit call). The two trades reflect different views by different players who happened to print on the same name on the same afternoon.

Either way, the combined signal is neutral-to-mildly-bullish — not bearish. The put is hedged; the call is bought.

---

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

CoreWeave has been a wild ride since its March 2025 IPO at $40. The stock ran to a 52-week high of ≈$173 before getting cut nearly in half — the August 2025 IPO lockup expiry wiped out ≈35% in two sessions when insiders sold over $1B of stock, per CNBC. Since then the name has rebuilt from lows, now trading ≈$95 — up ≈47% YTD from January 2026 but down ≈45% from the 52-week high.

Key observations:

• 📉 Post-IPO lockup scarring: The −35% drawdown in August 2025 shows how supply shocks hit this name — a recurring risk given further debt/equity raises likely ahead
• 📈 Rebuilt from lows: The stock has doubled off the post-lockup lows on the back of massive contract announcements (Meta $21B, NVIDIA $2B investment, OpenAI expansions)
• 🎢 Extreme volatility regime: The 52-week range spans $63.80–$173.35 — a 172% spread on a single stock. This is why IV runs 85–90% and why any options play here is inherently high-stakes
• ⚠️ Down ≈14% over the trailing month: The stock peaked near $187 and has retraced, which is the context for today's long-vol positioning

Gamma-Based Support & Resistance Analysis

Current spot: ≈$95.27

The gamma exposure map reveals a stock sitting on immediate support with a dominant wall just overhead:

🔵 Support Levels (Put Gamma Below Current Price):

• $95 — Immediate support, total GEX 4.34 (put GEX 3.15 dominant; net GEX −1.96). This is the closest gamma anchor to spot — a put-heavy zone where market maker hedging creates natural stabilizing flows. The stock has been testing this level.
• $90 — Moderate support, total GEX 3.92 (put GEX 3.49). A break of $95 would likely find buyers stepping in at $90.
• $85 — Secondary support, total GEX 3.21 (put GEX 2.95). Dense put positioning here; a move to this level would represent ≈11% downside.
• $80 — Support zone, total GEX 2.64 (put GEX 2.08). About 16% below current spot.
• $75 — The put cross strike itself, total GEX 1.18 (put GEX 1.07). Today's 4,000-contract cross adds meaningful put open interest at this level, reinforcing it as a longer-term structural anchor. ≈21% below spot.

🟠 Resistance Levels (Call Gamma Above Current Price):

• $100 — Strong resistance wall, total GEX 9.66 (the single dominant level in the data). This is the most important overhead level — nearly 2.5× the gamma of any other nearby strike. With put GEX of 7.49 and call GEX of 2.17, this is primarily a put gamma wall (net GEX −5.33), meaning market makers are heavily positioned here and will act as mechanical sellers if the stock approaches $100. This is the $97 call buyer's main obstacle.
• $105 — Secondary resistance, total GEX 4.41. Above the $100 wall, the next meaningful cluster.
• $110 — Resistance zone, total GEX 4.60.
• $115 — Strong call-gamma wall, total GEX 5.18 (call GEX 4.02 dominant; net GEX +2.87). Here the call gamma dominates — market makers are long calls and will sell into any rally toward this level.
• $120 — Strong resistance, total GEX 5.37 (call GEX 4.86 dominant; net GEX +4.35).

What this means for traders: CRWV is pinned between immediate put-gamma support at $95 and the dominant $100 resistance wall. The $97 call buyer needs the stock to punch through $100 (total GEX 9.66) — a significant technical hurdle — before the path to the ≈$104.40 breakeven opens. On the downside, $90 and $85 are the next meaningful support zones below $95.

Implied Move Analysis

The options market is pricing in extreme moves for CRWV across timeframes — consistent with the ≈85–90% IV regime:

Key reads for each trade:

For the $97 call (expires July 24, 2026): The July 17 monthly OPEX captures most of the relevant window (upper range $113.51, lower $77.03). The $97 strike sits ≈2.7% OTM, well within the implied range. The call buyer breaks even at $104.40 — within the weekly upper range of $103.52 (just barely) but firmly inside the monthly range of $113.51. The key obstacle, as the gamma data confirms, is the $100 resistance wall. A clean break above $100 would open the path toward the call's breakeven.

For the $75 put (expires Jun 17, 2027): The LEAPS implied range spans $12.85 – $177.69 (±86.51% over 353 days). The $75 strike sits comfortably inside the lower half of this range, meaning the market treats a move to $75 as a plausible (if not modal) scenario for a name with CRWV's volatility profile. However, as a delta-hedged position, the desk is not simply waiting for the stock to reach $75 — they are positioned to capture gamma and vega along the journey. The August 21 OPEX window (upper ≈$126.59, lower ≈$63.95) captures Q2 earnings (≈August 18) — a key binary event inside this put's lifetime.

Translation for regular traders: CRWV's options market is pricing in weekly moves of ≈$8, monthly moves of ≈$18, and a full-year range that spans from ≈$13 to ≈$178. In this environment, a $75 put at $18.45 is not "cheap insurance" — it is expensive insurance on an already-volatile name, which is exactly why the desk delta-hedged it rather than buying it naked.

---

🎪 Catalysts

✅ Recent Events (Already Happened)

Meta $21B Expansion — April 9, 2026

Meta committed an additional $21B of AI cloud capacity through December 2032, on top of a prior ≈$14.2B arrangement, bringing total Meta contracts to ≈$35B, per CNBC and CoreWeave. This is the single most important backlog anchor — a ≈$35B committed relationship with the world's largest social media company.

Q1 2026 Earnings — May 7, 2026

Revenue of $2.08B (+112% YoY), Q2 revenue guide of $2.45–2.6B, and a ≈$99.4B total backlog, per CNBC and CoreWeave IR. The EPS line missed by ≈$0.22, and free cash flow was −$4.7B — a reminder of how capital-intensive the growth story is. Full-year 2026 capex guided at $31–35B (raised from $30–35B).

NVIDIA $2B Equity Investment — January 26, 2026

NVIDIA invested $2B in CRWV Class A shares to expand data-center capacity, per CNBC. Beyond the capital, this is a strategic validation — NVIDIA, as both the GPU supplier and now an equity investor, has a direct interest in CoreWeave's success.

June 2026 Senior Notes Pricing

CoreWeave priced $1.25B of 9.625% notes due 2032 and €2B of 8.500% notes due 2032, per BusinessWire and CoreWeave IR. This is growth capital but at near-10% borrowing rates — a costly debt structure that adds to the ≈$21–25B total debt load.

Rosenblatt Initiates Buy, $250 Target — June 25, 2026

One of the most bullish Street calls, per public.com. Consensus sits at ≈Buy with a ≈$137 average target (range roughly $100–$250), per MarketBeat.

Failed Core Scientific Acquisition — October 30, 2025

CoreWeave's ≈$9B all-stock bid for ≈1.3 GW of data-center capacity was voted down by Core Scientific shareholders, per Core Scientific IR and DataCenterDynamics. Proxy advisers ISS and Glass Lewis argued the no-collar all-stock offer undervalued CORZ. The vertical-integration thesis took a hit; CRWV remains more reliant on leased capacity.

IPO Lockup Expiry — August 14, 2025 (the major dilution precedent)

≈83% of Class A shares unlocked; insiders sold over $1B, and the stock fell ≈35% over two sessions, per CNBC. This is the template for how supply shocks hit CRWV — and an important reason why a long-vol package (which profits from large moves) makes strategic sense in this name.

---

🔥 Upcoming Catalysts

Q2 2026 Earnings — ≈August 18, 2026 (THE Key Binary)

The next scheduled hard catalyst, per MarketBeat earnings and CoreWeave IR. The company guided Q2 revenue at $2.45–2.6B. Key metrics to watch:

• Active power: CoreWeave surpassed 1 GW in Q1 2026; the year-end target is >1.7 GW. Any operational miss here is a sharp downside trigger.
• Backlog trajectory: Can the $99.4B figure grow or hold? A flat or declining backlog would spook the market.
• Adjusted EBITDA margin: Was 56% in Q1 (down from 62% a year earlier). Margin compression + rising interest costs = the bear case in numbers.
• Interest expense / cash burn: With $31–35B of 2026 capex and near-10% borrowing rates, the FCF math is daunting. A wider-than-expected loss is historically a sharp downside trigger (see August 2025 reaction).

Important timing note: the $97 call (July 24, 2026) expires before Q2 earnings on August 18. The call buyer is betting on a near-term move in CRWV before the earnings binary, not on the earnings result itself. The $75 put (June 17, 2027) captures Q2 earnings, Q3 earnings (≈November 2026), and a full additional year of operating history.

Active Power Doubling to >1.7 GW (H2 2026)

The most important operational proof point, per DataCenterDynamics. Updates at Q2 (August) and Q3 (November) calls.

Further Debt / Equity Raises (Likely H2 2026)

With $31–35B of 2026 capex, additional term-loan draws, senior notes, or equity is probable. Each raise is a double-edged catalyst — funds growth but adds interest cost and dilution risk.

New Customer Contract Announcements (Unscheduled)

Given the quarterly cadence of OpenAI and Meta expansions, further backlog-additive announcements are possible in the next 6 months. These are the highest-magnitude positive catalysts but are unscheduled. CoreWeave now counts all four major AI labs (OpenAI, Meta, Anthropic, Google) as customers, per Augment.

---

🎲 Price Targets & Probabilities

Using the gamma levels and implied-move data as a framework (not a guarantee — CRWV is a high-dispersion name):

📈 Bull Case (25% probability)

Target: $110–$127 (upper end of Aug 21 OPEX cone ≈$126.59)

What gets us there:

• CRWV breaks cleanly above the $100 gamma wall (total GEX 9.66 — the dominant resistance)
• A new major customer announcement or NVIDIA-ecosystem partnership headline before July 24
• Positive CRWV commentary at an industry conference
• Gamma resistance at $105 and $110 gets absorbed by institutional buying
• $97 call buyer hits their breakeven at $104.40 and beyond
• Rosenblatt's $250 thesis gains traction; re-rating toward the $137 consensus PT

Key metrics needed: Clean close above $100 with volume; no new debt/equity dilution announcement in the near term.

🎯 Base Case (50% probability)

Target: $87–$103 consolidation range (within the weekly implied move)

Most likely near-term scenario:

• CRWV consolidates in the ≈$87–$103 weekly implied-move band
• The $100 gamma wall (total GEX 9.66) acts as a ceiling; $95 support (total GEX 4.34) provides a floor
• The $97 call expires worthless or with minimal value (stock stays below $97)
• The delta-hedged put position bleeds theta over time but provides gamma coverage on any large move
• Market waits for August 18 Q2 earnings as the next binary catalyst

This is the desk's working scenario for the hedged put: stock chops around, IV stays elevated, the long-vol package loses some theta but maintains gamma exposure into the Q2 binary.

📉 Bear Case (25% probability)

Target: $75–$87 (lower end of July implied move ≈$77.03; toward $75 gamma support)

What could go wrong:

• Further debt raise announced in July, triggering dilution concerns
• Q2 earnings pre-announcement or guidance warning before August 18
• Broader AI sentiment selloff (NVIDIA earnings disappointment; competitor wins from hyperscalers)
• DA Davidson's $100 PT target (cut from $175 on May 18, per public.com) proves prescient
• Break below $95 support → $90 → $85 gamma support levels tested
• The delta-hedged put position benefits here: gamma gains offset theta losses; the long put leg moves toward the money

---

💡 Trading Ideas — For 4 Types of Traders

🚀 YOLO Trader

"Copy the lit call — but know the wall"

The $97 call buyer on the lit tape (BUY, 90% NBBO) spent ≈$7.40 per contract for 1,500 contracts. If you're in this camp:

• The near-term play is a $97 call or similar strike in the July 17–July 24 window
• Breakeven at expiry: $104.40 — need a ≈10% move in ≈25 days
• The $100 resistance wall (total GEX 9.66) is the main hurdle — the stock has to punch through the dominant gamma wall before the breakeven is reachable
• 🎰 This is a speculative premium play; IV ≈85–90% makes these calls expensive. You can lose 100% if CRWV stays below $97
• Max risk: the $7.40/contract premium paid. Size accordingly — treat it as a lotto ticket, not a core position

⚖️ Swing Trader

"Play the $95 support / $100 resistance range"

CRWV is sandwiched between immediate $95 support and the powerful $100 gamma wall:

• 🐻 Bearish / range-bound: Sell a call spread above $100 (e.g., sell the $100/$105 call spread on a post-earnings or post-announcement spike). Collect premium while the $100 gamma wall does the work. Define your max loss as the spread width minus credit.
• 📈 Bullish on a dip: If CRWV pulls back to the $90 support zone (total GEX 3.92), consider buying September or October calls at the $100 strike — gives time for the $99.4B backlog narrative to play out and captures Q2 earnings on August 18. Avoid buying into current elevated IV if possible; wait for a vol event to crush it.

🛡️ Premium Collector

"Sell elevated vol via a defined-risk structure"

CRWV's IV ≈85–90% is rich. If you believe the base case (stock stays in the $87–$110 range for a few weeks):

• Sell the July 17 $75/$70 put spread + sell the July 17 $110/$115 call spread (iron condor)
• Put the short call strike at $110 (gamma resistance; total GEX 4.60) and short put strike at $75 (today's put cross strike — meaningful OI anchor)
• ⚠️ CRWV can move ±19% in 18 days (per implied-move data). This is not a low-risk trade. Size so that a full iron-condor loss is at most 2–3% of portfolio.
• The vol is the trade: you're betting CRWV's realized move is smaller than the ±19% implied

🌱 Beginner Investor

Real talk: These are complicated, high-IV trades on a volatile post-IPO name. The honest guidance:

• 👀 Watch, don't trade this yet. CRWV has ±8.67% weekly implied moves and ±19% monthly moves — in dollar terms, that's ±$8 and ±$18 swings. Options on a name this volatile can go to zero quickly.
• 📅 Mark August 18 on your calendar — Q2 2026 earnings is the next major binary event. If earnings are strong and the stock pops, consider a small long stock position after the IV crush (options get cheaper post-earnings, making the risk/reward better).
• 🛡️ Start with defined-risk positions only. If you want to participate, buy a debit call spread (e.g., buy the $95 call, sell the $105 call, same expiry). Your max loss is capped at the spread debit; your max gain is the $10 width minus the debit. Never sell naked options on a ±85% IV stock.
• 📚 Understand the business first: CRWV is not a safe, dividend-paying blue chip. It is an aggressive, debt-heavy AI-infrastructure play that can move 30–40% in either direction on a single headline.

---

⚠️ Risk Factors

What could go wrong — and what the tape cannot tell you:

• 🏦 The $100 gamma wall is the immediate ceiling: Total GEX of 9.66 at the $100 strike is nearly 2.5× any other nearby level. Market makers hedging their exposure will systematically sell into any rally toward $100 — the $97 call buyer needs to break through this wall to profit.

• 💸 Options are expensive at IV ≈85–90%: Theta decay burns fast. The $75 put cost $18.45 at a IV likely near 90% — a full-year position with significant daily theta. Even for the delta-hedged desk, the carrying cost of this position is substantial. The $97 call at $7.40 with 25 days to expiry also decays quickly if the stock goes nowhere.

• 📉 Debt and dilution are structural risks: ≈$21–25B of total debt at near-10% borrowing rates (June 2026 notes priced at 8.5–9.625%), per CoreWeave IR. With $31–35B of 2026 capex and −$4.7B quarterly FCF, CRWV will likely need to raise more capital in H2 2026. Each raise is a potential supply shock — the August 2025 lockup (−35% in two sessions) is the playbook.

• 🤝 What the tape cannot prove on the put cross:

  • The sign (buy/sell) of the QCT stock block — which party was buying vs. selling in the negotiated cross
  • Whether the put + stock package is net long or short delta after accounting for the cross sign
  • The identity, broker, motive, or portfolio context of the desk
  • Whether the $75 put and the $97 call are the same desk or two different desks

• 🎯 Customer concentration: CoreWeave's ≈$99.4B backlog is anchored by a handful of names — primarily Meta ($35B) and OpenAI (≈$22.4B). Any renegotiation, delay, or pullback by either anchor customer would materially impair the backlog narrative and likely trigger a sharp stock move.

• ⚠️ NVIDIA dependence: Supply allocation, pricing, and GPU-generation transitions (e.g., depreciation risk on prior-gen GPUs) sit largely outside CoreWeave's control. NVIDIA is both a key supplier and a ≈$2B equity investor — an alignment that could shift.

• 📊 DA Davidson cut to $100 target (May 18): The downgrade from $175 to $100 per public.com reflects genuine concern that rising data-center construction costs (estimated at $15–25M per MW, per The Motley Fool) could break the unit economics before the $99.4B backlog fully monetizes. The stock is currently right at that $100 analyst target.

• 🏗️ Execution risk post-Core Scientific: The failed ≈$9B acquisition of Core Scientific leaves CRWV more reliant on leased capacity and self-build to reach its 8+ GW 2030 target, per DataCenterDynamics. This is a structural headwind that will take quarters to resolve.

---

🎯 The Bottom Line

Here's the deal: Two distinct CRWV tape events today — but neither one is the straightforward bearish bet a surface-level read would suggest.

The $7.4M put cross: Pre-arranged QCC block, paired with a 96,000-share QCT stock block (≈$8.94M) that delta-matches the option position. This is a long-volatility / protective-put package, not a downside directional bet. The desk is positioned to benefit from large moves or rising implied volatility — appropriate positioning for a name with ≈85–90% IV, ≈35% intraday moves in its history, and a Q2 earnings binary on August 18.

The $1.1M call buy: Near-term (July 24, 2026), lit tape, 90% NBBO aggressor, size 1,500 vs. only 78 prior OI — a fresh, confident bullish BTO. The screenshot said "SELL." The tape says "BUY." The tape wins. Breakeven at $104.40, main obstacle is the $100 gamma wall (total GEX 9.66).

What the combined print signals:

• 🔍 One desk (or two) is comfortable owning long-vol exposure in CRWV — appropriate for the binary environment ahead
• 📈 The cleaner directional read is the $1.1M call BUY, not the $7.4M hedged put
• ⚖️ Neither print is a simple "CRWV is going to fall" or "CRWV is going to $75" read — anyone presenting it that way has missed the stock block

If you own CRWV:

• ✅ The $95 gamma support (total GEX 4.34) is your immediate near-term floor — a dip there is mechanically supported
• 📅 Mark August 18 as the decision point — Q2 earnings will either confirm the backlog-conversion thesis or expose the leverage risk
• ⚠️ The $100 gamma wall (total GEX 9.66) is strong overhead resistance — trimming partial exposure on a push toward $100–$105 is rational risk management near analyst consensus (DA Davidson target $100)

If you're watching from the sidelines:

• 📅 August 18 Q2 earnings is the moment of truth — wait for the print before making a large directional bet
• 🎯 A pullback toward $90 support (total GEX 3.92) or $85 (total GEX 3.21) would offer a better risk/reward entry for the longer-term AI-infrastructure thesis
• 📊 Watch for: active power updates (target >1.7 GW by year-end), backlog trajectory at Q2, and any new major customer announcement before earnings

If you're bearish:

• 📉 The DA Davidson $100 target acts as the first gravitational ceiling; a miss on Q2 earnings could send the stock toward $85–$90 gamma support
• 🛡️ Put spreads or defined-risk structures are the right approach — not naked puts on a name that can gap 12% on a single announcement
• ⚠️ Don't fight the backlog: $99.4B in contracted revenue from Meta and OpenAI is not noise. CRWV's bear thesis is leverage and execution risk, not demand risk.

Mark your calendar:

• ✅ June 30, 2026 (≈06:30 ET) — DONE: Next-day OPRA OI resolved both flags as OPEN — $75 put 1,808 → 5,751 (Δ +3,943, ≈99% net-new) and $97 call 78 → 1,580 (Δ +1,502, full size). No inversion; the long-vol-put + bullish-call read holds.
• 📅 July 2, 2026 — Weekly expiration: ±$8.26 implied range $87.00–$103.52
• 📅 July 17, 2026 — Monthly OPEX: ±$18.24 implied range $77.03–$113.51
• 📅 July 24, 2026 — $97 call expires
• 📅 ≈August 18, 2026 — Q2 2026 earnings (the binary catalyst inside the $75 put's lifetime), per MarketBeat
• 📅 H2 2026 — Active power target >1.7 GW; probable further debt/equity raises
• 📅 June 17, 2027 — $75 put expires (captures Q2, Q3 earnings, plus a full year of operating history)

Final verdict: CoreWeave is one of the most compelling and most dangerous stocks in the AI universe simultaneously — record $99.4B backlog, Meta's $35B commitment, NVIDIA backing, and 112% revenue growth on one side; near-10% borrowing costs, −$4.7B quarterly FCF, and a stock that has cut 45% from its highs on the other. The smart money today isn't simply betting the stock goes down or up — they are buying long-vol insurance and near-term call upside in a name where the next ±20% move is already priced in. Follow their lead: respect the volatility, understand the structure, and wait for August 18 earnings before making a large unhedged directional bet.

---

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational and informational purposes only and does not constitute financial advice. The tape interpretation presented here — including the delta-hedge inference, the open/close determination, and the screenshot correction — involves analysis of public OPRA data and is not guaranteed to be accurate. The Qualified Contingent Trade (QCT) stock block's directional sign is not disclosed on the public options tape; the delta-hedge interpretation is inferred from the size match and timing and is not proven. CRWV is a young, highly volatile, heavily-levered post-IPO company; options positions can go to zero rapidly in this name. The $75 put and $97 call figures cited represent the OI change predicted based on current data — actual next-day OI may differ. Always conduct your own due diligence and consider consulting a licensed financial advisor before trading. Past unusual options activity does not predict future stock performance. Q2 2026 earnings dates and financial figures cited are sourced from public disclosures and should be verified before any trading decision.

---

CoreWeave (CRWV) — Ticker: NASDAQ: CRWV | Market Cap: ≈$52–53B | Sector: Information Technology — AI/Cloud Infrastructure | Q2 2026 Earnings: ≈August 18, 2026

Last updated: 2026-06-30 — next-day OPRA OI resolved both open/close flags (see ✅ RESOLVED box).